financetom
Business
financetom
/
Business
/
DLP Resources Raises $6.4 Million by Closing Private Placement Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
DLP Resources Raises $6.4 Million by Closing Private Placement Offering
May 3, 2024 10:01 AM

12:37 PM EDT, 05/03/2024 (MT Newswires) -- DLP Resources ( DLPRF ) said Friday that it has raised more than $6.4 million, by completing a brokered offering for about $4.8 million and a non-brokered offering for about $1.6 million.

DLP issued about 16.1 million units at $0.40 apiece under the offering, comprised of about 12.1 million units issued under the brokered offering and about 4 million units issued under the non-brokered offering.

Each unit is comprised of one common share and one common share purchase warrant. Each warrant will allow the holder to buy one common share at an exercise price of $0.54 per warrant share for 36 months from the closing of the offering.

The company plans to use the proceeds for exploration and development and general working capital purposes.

Price: 0.40, Change: -0.01, Percent Change: -2.44

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Solid Biosciences Shares Up After Positive Results From Duchenne Drug Study, Prices $200 Million Offering
Solid Biosciences Shares Up After Positive Results From Duchenne Drug Study, Prices $200 Million Offering
Feb 18, 2025
03:27 PM EST, 02/18/2025 (MT Newswires) -- Solid Biosciences ( SLDB ) shares were up almost 34% in Tuesday trading after the company said a phase 1/2 trial of its gene therapy candidate SGT-003 for Duchenne muscular dystrophy yielded positive data. Preliminary 90-day biopsy results from the initial three participants demonstrated a mean microdystrophin expression level of 110%, as assessed...
Market Chatter: Merck Agrees to Halt Gardasil Trial Until September
Market Chatter: Merck Agrees to Halt Gardasil Trial Until September
Feb 18, 2025
03:17 PM EST, 02/18/2025 (MT Newswires) -- Merck ( MRK ) and a plaintiff suing the company over its human papillomavirus vaccine, Gardasil, have agreed to halt a trial after four weeks of proceedings, Reuters reported Tuesday, citing a company statement. The plaintiff, Jennifer Robi, alleges that the vaccine caused her impaired mobility. On Friday, the plaintiff's lawyers proposed discharging...
Huntsman Corporation Shares Are Up Today: What's Going On?
Huntsman Corporation Shares Are Up Today: What's Going On?
Feb 18, 2025
Huntsman Corporation ( HUN ) shares are trading higher Tuesday after the company reported better-than-expected revenue for the fourth quarter of 2024. What’s Going On: Huntsman posted a quarterly loss of 25 cents per share, which was significantly below analysts’ expectations of a 10-cent loss. This also marked a deeper decline compared to the 21 cents per share loss in...
Merus Shares Are Up Today: What's Going On?
Merus Shares Are Up Today: What's Going On?
Feb 18, 2025
Shares of Merus N.V. ( MRUS ) are trading higher Tuesday after the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to petosemtamab in combination with pembrolizumab. What To Know: The designation applies to the first-line treatment of adult patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma (r/m HNSCC) with a combined...
Copyright 2023-2026 - www.financetom.com All Rights Reserved